4//SEC Filing
Mitchell Shawnte 4
Accession 0001019056-18-000956
CIK 0001671584other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:45 PM ET
Size
8.5 KB
Accession
0001019056-18-000956
Insider Transaction Report
Form 4
Mitchell Shawnte
SVP, GC and Corporate Affairs
Transactions
- Exercise/Conversion
Common Stock
2018-08-09+1,630→ 76,135 total - Tax Payment
Common Stock
2018-08-09$4.50/sh−383$1,724→ 75,752 total - Exercise/Conversion
Restricted Stock Units
2018-08-09−1,630→ 6,787 total→ Common Stock (1,630 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis.
- [F2]On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001749432
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:45 PM ET
- Size
- 8.5 KB